全文获取类型
| 收费全文 | 982222篇 |
| 免费 | 71684篇 |
| 国内免费 | 1441篇 |
专业分类
| 耳鼻咽喉 | 13420篇 |
| 儿科学 | 26260篇 |
| 妇产科学 | 24613篇 |
| 基础医学 | 139496篇 |
| 口腔科学 | 28722篇 |
| 临床医学 | 87233篇 |
| 内科学 | 192523篇 |
| 皮肤病学 | 20215篇 |
| 神经病学 | 77310篇 |
| 特种医学 | 37994篇 |
| 外国民族医学 | 79篇 |
| 外科学 | 157531篇 |
| 综合类 | 18544篇 |
| 现状与发展 | 2篇 |
| 一般理论 | 329篇 |
| 预防医学 | 69012篇 |
| 眼科学 | 22209篇 |
| 药学 | 76173篇 |
| 3篇 | |
| 中国医学 | 2218篇 |
| 肿瘤学 | 61461篇 |
出版年
| 2021年 | 7331篇 |
| 2019年 | 7652篇 |
| 2018年 | 10817篇 |
| 2017年 | 8443篇 |
| 2016年 | 9287篇 |
| 2015年 | 10442篇 |
| 2014年 | 14233篇 |
| 2013年 | 20462篇 |
| 2012年 | 28539篇 |
| 2011年 | 29383篇 |
| 2010年 | 17207篇 |
| 2009年 | 16229篇 |
| 2008年 | 28117篇 |
| 2007年 | 29166篇 |
| 2006年 | 29711篇 |
| 2005年 | 28442篇 |
| 2004年 | 27202篇 |
| 2003年 | 25841篇 |
| 2002年 | 25101篇 |
| 2001年 | 55115篇 |
| 2000年 | 56863篇 |
| 1999年 | 47326篇 |
| 1998年 | 11099篇 |
| 1997年 | 9730篇 |
| 1996年 | 9823篇 |
| 1995年 | 9129篇 |
| 1994年 | 8450篇 |
| 1993年 | 7724篇 |
| 1992年 | 35694篇 |
| 1991年 | 34102篇 |
| 1990年 | 32911篇 |
| 1989年 | 32067篇 |
| 1988年 | 29144篇 |
| 1987年 | 28388篇 |
| 1986年 | 26422篇 |
| 1985年 | 25283篇 |
| 1984年 | 17928篇 |
| 1983年 | 15265篇 |
| 1982年 | 7851篇 |
| 1979年 | 15860篇 |
| 1978年 | 10665篇 |
| 1977年 | 9117篇 |
| 1976年 | 7946篇 |
| 1975年 | 8702篇 |
| 1974年 | 10534篇 |
| 1973年 | 9944篇 |
| 1972年 | 9424篇 |
| 1971年 | 8898篇 |
| 1970年 | 8462篇 |
| 1969年 | 7957篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
101.
Julia Thornton Snider Jesse Sussell Mahlet Gizaw Tebeka Alicia Gonzalez Joshua T. Cohen Peter Neumann 《Value in health》2019,22(3):332-339
Background
Payers frequently rely on budget impact model (BIM) results to help determine drug coverage policy and its effect on their bottom line. It is unclear whether BIMs typically overestimate or underestimate real-world budget impact.Objective
We examined how different modeling assumptions influenced the results of 6 BIMs from the Institute for Clinical and Economic Review (ICER).Study Design
Retrospective analysis of pharmaceutical sales data.Methods
From ICER reports issued before 2016, we collected estimates of 3 BIM outputs: aggregate therapy cost (ie, cost to treat the patient population with a particular therapy), therapy uptake, and price. We compared these against real-world estimates that we generated using drug sales data. We considered 2 classes of BIM estimates: those forecasting future uptake of new agents, which assumed “unmanaged uptake,” and those describing the contemporaneous market state (ie, estimates of current, managed uptake and budget impact for compounds already on the market).Results
Differences between ICER's estimates and our own were largest for forecasted studies. Here, ICER's uptake estimates exceeded real-world estimates by factors ranging from 7.4 (sacubitril/valsartan) to 54 (hepatitis C treatments). The “unmanaged uptake” assumption (removed from ICER's approach in 2017) yields large deviations between BIM estimates and real-world consumption. Nevertheless, in some cases, ICER's BIMs that relied on current market estimates also deviated substantially from real-world sales data.Conclusions
This study highlights challenges with forecasting budget impact. In particular, assumptions about uptake and data source selection can greatly influence the accuracy of results. 相似文献102.
Eloise R. Galligan Lindsey Fix Sameera Husain Philip Zachariah Darrell J. Yamashiro Christine T. Lauren 《Journal of cutaneous pathology》2019,46(2):159-161
We report a case of disseminated Trichosporon asahii in a patient on systemic antifungal therapy who presented with multiple cutaneous nodules suggestive of fungal infection. Histologic features resembled neutrophilic eccrine hidradenitis but staining with periodic acid‐Schiff and Gomori methenamine silver confirmed the clinical diagnosis. This case highlights the importance of maintaining suspicion for trichosporonosis and contextualizing histologic findings within the underlying clinical picture. 相似文献
103.
104.
105.
Eloise R. Galligan Leila H. Shayegan Christine T. Lauren Kimberly D. Morel 《Pediatric dermatology》2019,36(5):753-754
Shaving and other modes of epilation can cause undue anxiety, pain, or skin irritation in children. Here, we present hair trimming as a safe, painless, and cost‐effective alternative for patients with unwanted hair which may be performed indefinitely or until the child is old enough to direct management. In select cases, removing unwanted hair using this technique may facilitate dermatologic surveillance. 相似文献
106.
Clint R. Bellenger John B. Arnold Jonathan D. Buckley Dominic Thewlis Joel T. Fuller 《Journal of Science and Medicine in Sport》2019,22(3):294-299
Objectives
To investigate whether functional overreaching affects locomotor system behaviour when running at fixed relative intensities and if any effects were associated with changes in running performance.Design
Prospective intervention study.Methods
Ten trained male runners completed three training blocks in a fixed order. Training consisted of one week of light training (baseline), two weeks of heavy training designed to induce functional overreaching, and ten days of light taper training designed to allow athletes to recover from, and adapt to, the heavy training. Locomotor behaviour, 5-km time trial performance, and subjective reports of training status (Daily Analysis of Life Demands for Athletes (DALDA) questionnaire) were assessed at the completion of each training block. Locomotor behaviour was assessed using detrended fluctuation analysis of stride intervals during running at speeds corresponding to 65% and 85% of maximum heart rate (HRmax) at baseline.Results
Time trial performance (effect size ±95% confidence interval (ES): 0.16 ± 0.06; p < 0.001), locomotor behaviour at 65% HRmax (ES: ?1.12 ± 0.95; p = 0.026), and DALDA (ES: 2.55 ± 0.80; p < 0.001) were all detrimentally affected by the heavy training. Time trial performance improved relative to baseline after the taper (ES: ?0.16 ± 0.10; p = 0.003) but locomotor behaviour at 65% HRmax (ES: ?1.18 ± 1.17; p = 0.048) and DALDA (ES: 0.92 ± 0.90; p = 0.045) remained impaired.Conclusions
Locomotor behaviour during running at 65% HRmax was impaired by functional overreaching and remained impaired after a 10-day taper, despite improved running performance. Locomotor changes may increase injury risk and should be considered within athlete monitoring programs independently of performance changes. 相似文献107.
Gordon K. B. Saburov V. O. Koryakin S. N. Gulidov I. A. Fatkhudinov T. Kh. Arutyunyan I. V. Kaprin A. D. Solov’ev A. N. 《Bulletin of experimental biology and medicine》2022,173(2):281-285
Bulletin of Experimental Biology and Medicine - Fast neutron therapy, which previously has demonstrated effective results, but along with a large number of complications, can again be considered a... 相似文献
108.
109.
Denise Lee Marcella D. Walker Hsin Yi Chen John A. Chabot James A. Lee Jennifer H. Kuo 《Surgery》2019,165(1):107-113
Background
Bone mineral density (BMD) has been found to improve after parathyroidectomy (PTX) in patients with primary hyperparathyroidism. There are few data on the effect of PTX on BMD in normocalcemic and normohormonal primary hyperparathyroidism.Methods
A retrospective analysis of 92 primary hyperparathyroidism patients who underwent PTX between 2004 and 2012 with pre- and post-PTX dual-energy x-ray absorptiometry was performed. Within-person changes in BMD pre- and post-PTX were analyzed using log linear mixed models, stratified by biochemical status.Results
Bone mineral density increased post-PTX in the whole cohort at the lumbar spine (+2.5%), femoral neck (+2.1%), and total hip (+1.9%) and decreased at the one-third radius (–0.9%). On comparison of BMD changes by profile, BMD increased in those with the typical profile at the lumbar spine (3.2%), femoral neck (2.9%), and total hip (2.9%) but declined at the one-third radius (–1.5%). In contrast, BMD improved only at the femoral neck (4.3%) in the normohormonal group and did not change at any site in the normocalcemic group. The typical group had a greater increase in BMD over time at the femoral neck and total hip compared with normocalcemic patients.Conclusion
Our results indicate that the skeletal benefit of PTX was attenuated in normocalcemic and normohormonal patients, suggesting that skeletal changes after PTX may depend on biochemical profile. 相似文献110.